Aegis is the bookrunner; Chardan, Barrington Research also will assist
By Devika Patel
Knoxville, Tenn., June 24 – Ritter Pharmaceuticals Inc. said it priced its $20 million initial public offering of stock with a $3 million greenshoe. The deal was announced June 4.
The company will sell 4 million common shares at $5.00 apiece.
Aegis Capital Corp. is the bookrunning manager.
Settlement is expected June 29.
The Research Triangle Park, N.C., pharmaceutical company develops therapeutics to treat kidney disease. The company’s expects its shares will trade on the Nasdaq under the symbol “RTTR.”
| Issuer: | Ritter Pharmaceuticals Inc.
|
| Issue: | Common stock
|
| Amount: | $20 million
|
| Greenshoe: | $3 million, or 600,000 shares
|
| Shares: | 4 million
|
| Price: | $5.00
|
| Warrants: | No
|
| Bookrunner: | Aegis Capital Corp.
|
| Lead manager: | Chardan Capital Markets, LLC
|
| Co-manager: | Barrington Research
|
| Announcement date: | June 4
|
| Pricing date: | June 24
|
| Settlement date: | June 29
|
| Stock exchange: | Nasdaq: RTTR
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
